McElhenny Sheffield Capital Management LLC Sells 915 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

McElhenny Sheffield Capital Management LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 47.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,033 shares of the healthcare conglomerate’s stock after selling 915 shares during the period. McElhenny Sheffield Capital Management LLC’s holdings in UnitedHealth Group were worth $604,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Kathleen S. Wright Associates Inc. bought a new stake in UnitedHealth Group in the 3rd quarter valued at about $27,000. Global Wealth Strategies & Associates boosted its stake in shares of UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 32 shares during the period. Macroview Investment Management LLC increased its stake in UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares during the period. West Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter worth $32,000. Finally, Delos Wealth Advisors LLC raised its stake in UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 53 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. UBS Group dropped their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Cantor Fitzgerald lifted their target price on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. Barclays lifted their price target on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. KeyCorp assumed coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 target price on the stock. Finally, Stephens cut their price objective on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Three analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $615.58.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $569.61 on Monday. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market cap of $525.99 billion, a price-to-earnings ratio of 37.11, a PEG ratio of 1.67 and a beta of 0.58. The business’s fifty day moving average is $584.42 and its 200 day moving average is $534.68. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $608.63.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.56 EPS. Research analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.47%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.